ADHD: Clinical Trials

3 trials for ADHD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Terminated 3

Follow ADHD: new trials by email Literature Review of ADHD trials Research Report on ADHD

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neurophysiological Markers of Pediatric Irritability and Its Response to Intervention
CNS Stimulant - ADHD
Phase 4TerminatedMilton S. Hershey Medical Center112018-06-012025-08-26
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Naltrexone, Placebo - ADHD, Attention Deficit Hyperactivity Disorder
Phase 4TerminatedMassachusetts General Hospital32012-11-012016-05-27
Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA)
Immediate release methylphenidate (MedikinetĀ®), Extended release methylphenidate (Medikinet retardĀ®) - ADHD
Phase 4TerminatedProf. Huss322009-03-012014-05-07

Narrower conditions

Attention Deficit Disorder with Hyperactivity (3)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (3)  ·  Mental Disorders (3)  ·  Neurodevelopmental Disorders (3)

Interventions

Central Nervous System Stimulants (1)  ·  Naltrexone (1)

Sponsors

Massachusetts General Hospital (1)  ·  Milton S. Hershey Medical Center (1)  ·  Prof. Huss (1)

Countries

United States (2)  ·  Germany (1)

Top investigators

Michael Huss, Prof. Dr. (1)  ·  Raman Baweja, MD, MS (1)  ·  Thomas J Spencer, MD (1)